This approach was used to improve the capacity of poly(2-(methacryloyloxy)ethyl phosphorylcholine)-poly(2-(diisopropylamino)ethyl methacrylate) (PMPC-PDPA) polymersomes to target the scavenger receptor class B member 1 (SRB1) and scavenger receptor class B member 3 (CD36) present on the surface of tuberculosis- and Staphylococcus aureus-infected macrophages or cancer cells [10]. Here, CD36 is linked to cancer.